Three out of 16 primary HCC cells exhibited MET gene amplification, which were also positive for elevated MET protein expression (IHC 3+) in HCC tissues, and showed higher sensitive to NZ001 treatment compared with other cells (Fig. 7d; Additional file 1: Table S7, 8). This evidence concerns the gene MET and hepatocellular carcinoma.